Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-Britain's FTSE hits one-month high as banks and miners lead cyclical charge

Wed, 07th Dec 2016 17:15

* FTSE 100 up 1.8 pct

* Banks hit 1 1/2-year high

* Rio benefits from Credit Suisse upgrade

* WPP falls on reported DOJ probe (Recasts, adds detail and updates prices at close)

By Kit Rees and Alistair Smout

LONDON, Dec 7 (Reuters) - Britain's top share index rose toa one-month high on Wednesday, rallying for a third straightsession as investors snapped up bank and mining stocks androtated out of more "defensive" parts of the market.

The British FTSE 100 was up 1.8 percent to 6,902.23points at its close, its highest closing level since Nov. 9.

Financials contributed 47 points to the rise, supported bygains in euro zone lenders. Italian banks continued to rally offof lows hit after the Italian prime minister said he wouldresign after voters rejected his reforms in a referendum.

Barclays rose 3.6 percent, its highest level thisyear. Royal Bank of Scotland rose 3.9 percent to itshighest point since Britain voted in June to leave the EuropeanUnion.

In all, banks were up 3.9 percent, reaching a 11/2-year high. Lloyds and Standard Chartered led the sector, both gaining more than 4 percent.

"In the UK but also more broadly, people are rotating intofinancials on expectations of higher inflation and higheryields," said Jasper Lawler, senior market analyst at LondonCapital Group, adding that the European Central Bank could helpto support the sector when it meets on Thursday.

Mining stocks were also strong gainers, with Rio Tinto the top gainer on the FTSE 100, up 6.6 percent as itbenefited from an upgrade by Credit Suisse.

The global miner was lifted to "outperform" from "neutral"by the Swiss bank, who raised its target price on the stock to3,600 pence from 2,750 pence.

Peer BHP Billiton rose 3.9 percent, buoyed by risingcopper prices, but lagged as it was downgraded to "neutral".

"With an improvement in laggard commodities like thermalcoal and copper (and, to a lesser extent, aluminium), and withiron ore exhibiting less downside risk versus coking coal forBHP, we believe Rio now has the better earnings outlook for theyear ahead," analysts at Credit Suisse said in a note.

Among fallers, advertiser WPP dropped 2.8 percentafter a report that the U.S. Justice Department wasinvestigating the industry.

Stocks such as consumer staple Unilever and pharmafirm Shire dropped as investors moved out of "expensivedefensives" to take on more risk. Unilever was knocked by adowngrade from JP Morgan, while Shire suffered from a downgradeby UBS.

Healthcare stocks were also hit after U.S. President-electDonald Trump said that he would "bring down drug prices", withshares in midcap Indivior falling almost 5 percent.

However, while analysts are cautious over possible marketshocks following a series of political upsets this year,according to a Reuters poll of strategists, brokers and analyststaken over the past week. It showed that European shares areexpected to rise steadily in 2017. (Reporting by Kit Rees and Alistair Smout, editing by LarryKing)

More News
6 Sep 2019 07:54

UPDATE 1-Sumitomo Dainippon Pharma investing $3 bln in Swiss Roivant in overseas push

* Dainippon to buy 10% stake in Roivant and interests in 5 units * Schizophrenia treatment Latuda to lose US exclusivity in 2023 * Japan pharma firms grapple with declining Dainippon

Read more
14 Aug 2019 06:45

UPDATE 1-Germany's Stada 'very selective' on acquisitions - CEO Goldschmidt

FRANKFURT, Aug 14 (Reuters) - German generic drugmaker Stada will be careful about buying businesses and companies outright, and for now will focus mainly on striking production and development we

Read more
17 Jul 2019 17:55

Takeda kicks off sale of Western European drugs - sources

By Arno Schuetze and Pamela Barbaglia FRANKFURT/LONDON, July 17 (Reuters) - Japan's Takeda Pharmaceutical Co has reached out to prospective bidders for a portfolio of drugs for sale in

Read more
16 May 2019 18:35

Japan's Takeda expects binding offers for Latam business by end of May -sources

By Tatiana Bautzer SAO PAULO, May 16 (Reuters) - Japan's Takeda Pharmaceutical Co expects to receive binding offers for its Latin American business by the end of May, three sources of a

Read more
15 May 2019 08:05

Nikkei snaps 7-day losing streak helped by China's stimulus hopes

* Gains may be short-lived - analyst * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi Estate jumps on share buyback, governance reform By Hideyuki Sano and Ayai

Read more
15 May 2019 04:04

Nikkei hobbled by trade worries, disappointing earnings

* Nikkei down slightly after 7 losing sessions * Uncertainties over U.S.-China standoff keep investors on edge * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi -

Read more
14 May 2019 07:56

UPDATE 1-Japan's Takeda forecasts 193 bln yen annual operating loss on Shire deal

* 193 bln Y op loss forecast this yr vs 227.5 bln profit view of analysts * Shire acquisition made Takeda one of the world's most indebted drugmakers (Adds details of results, May 14 -

Read more
14 May 2019 07:39

Japan's Takeda expects annual loss on Shire deal

TOKYO, May 14 (Reuters) - Takeda Pharmaceutical Co forecast on Tuesday it would have an operating loss in the current financial year, as it books costs associated with the multibillion-dollar an a

Read more
9 May 2019 00:38

UPDATE 1-Novartis buys Takeda's dry eye drug for $3.4 bln

May 8 (Reuters) - Swiss drugmaker Novartis AG said on Wednesday it agreed to acquire Takeda Pharmaceutical Company Ltd's dry eye drug Xiidra for $3.4 billion, as well as potential milestone of

Read more
1 Feb 2019 06:07

Japan's Takeda posts 28 pct rise in Q3 operating profit

TOKYO, Feb 1 (Reuters) - Takeda Pharmaceutical Co Ltd on Friday posted a 27.9 percent rise in third-quarter operating profit, supported by strong sales of its drugs for bowel disease and multiple

Read more
22 Jan 2019 02:46

Nikkei dips as global growth concerns sap risk appetite

* IMF cuts global growth forecasts * Companies with big China exposure fall * Totech soars after raising earnings forecast By Ayai Tomisawa TOKYO, Jan 22 (Reuters) - in

Read more
8 Jan 2019 13:54

MARKET ANALYSIS: Optimism About Trade Talks May Generate Continued Buying Interest

WASHINGTON (Alliance News) - The major US index futures are pointing to a higher opening on Tuesday, with stocks likely to extend the strong upward move seen over the two previous about trade the

Read more
8 Jan 2019 08:58

Asian Shares Mixed Despite US-China Trade Deal Optimism

CANBERA (Alliance News) - Asian stocks ended mixed on Tuesday despite optimism over US-China trade talks as US officials held a second day of trade talks with Chinese counterparts in second day of

Read more
8 Jan 2019 07:39

Takeda takes control of Shire

(Sharecast News) - Takeda Pharmaceutical has taken full control of Shire after the legal particulars of its cash and share offer were completed.

Read more
7 Jan 2019 04:29

Takeda unlikely to sell OTC drug business -CEO

(Adds quote, other details) TOKYO, Jan 7 (Reuters) - Takeda Pharmaceutical is unlikely to sell its over-the-counter (OTC) drug business even amid pressure to improve its finances as it a a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.